Search results for "coronary disease."

showing 10 items of 202 documents

Aneurysms of the coronary arteries in infants and children. A review, and report of six cases.

1977

In recent years large numbers of the so-called “mucocutaneous lymph node syndrome” or “Kawasaki's disease” have been described by Japanese workers, but instances of this disorder are only now being reported as isolated cases by European or North American physicians. The disease has, therefore, been considered to be a new entity. One of its most striking features is the development of aneurysms of the coronary arteries in infants or children, which may lead to sudden death. Aneurysms of the coronary arteries in childhood are rare, and hence it was considered relevant to report six such cases, and to examine their possible relationship to Kawasaki's disease. The pathological changes underlyin…

Malemedicine.medical_specialtyHistologyCoronary DiseaseDiseaseSudden deathPathology and Forensic Medicinehemic and lymphatic diseasesmedicineHumanscardiovascular diseasesHeart Aneurysmskin and connective tissue diseasesMolecular BiologyPathologicalLymphatic DiseasesSkinMucous Membranebusiness.industryPolyarteritis nodosaAge FactorsInfantCell BiologyGeneral MedicineSyndromemedicine.diseaseDermatologyMucocutaneous Lymph Node SyndromePolyarteritis NodosaCoronary arteriesmedicine.anatomical_structureChild PreschoolFemaleAnatomyInfantile Polyarteritis NodosabusinessIsolated casesVirchows Archiv. A, Pathological anatomy and histology
researchProduct

Clinical indicators of periodontal disease in patients with coronary heart disease : a 10 years longitudinal study

2011

Objectives: There is evidence about a possible relationship existing between periodontal diseases and coronary heart disease. The aim of the present longitudinal study was to investigate the changes in periodontal evolution after etiological periodontal treatment, comparing a healthy control group with another having coronary heart disease. Study Design: The study included initially 55 patients of which 44 finished it. They were placed into two groups: Healthy Control Group (HCG) n =9, and Coronary Heart Disease Group (CHDG) n=35. The gingival level (GL), probing depth (PD), clinical attachment level (CAL), plaque index (PI) and bleeding on probing (BOP) were measured to compare the periodo…

Malemedicine.medical_specialtyLongitudinal studyTime FactorsPlaque indexBleeding on probingDentistryCoronary DiseaseGastroenterologyPeriodontal diseaseInternal medicinemedicineHumansIn patientLongitudinal StudiesPeriodontal IndicesGeneral DentistryPeriodontal Diseasesbusiness.industry:CIENCIAS MÉDICAS [UNESCO]Coronary heart diseaseOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASEtiologyFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgeryPeriodontal Indexmedicine.symptombusiness
researchProduct

Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart.

1991

The glutathione redox pathway is an important antioxidant system in the myocardium. N-Acetylcysteine is a low molecular weight glutathione precursor that has been used clinically to replenish glutathione stores. The present study was aimed at evaluating the protective effect of N-acetylcysteine on myocardial damage resulting from permanent coronary occlusion (without reperfusion) in anaesthetized dogs. N-Acetylcysteine (150 mg kg−1 i.v.) administered 2 min before occlusion rerduced infarct size in dogs subjected to 24 h ischemia. The infarct size as a percentage of the area at risk was 86.8 ± 3.6% (n = 11) in control (salinetreated) dogs and 68.2 ± 2.4% (n = 7; P < 0.05 vs control) in N-ace…

Malemedicine.medical_specialtyMean arterial pressureTime FactorsIschemiaMyocardial InfarctionHemodynamicsCoronary DiseaseAcetylcysteinechemistry.chemical_compoundDogsInternal medicineCoronary CirculationmedicineAnimalsMyocardial infarctionPharmacologybusiness.industryGeneral MedicineGlutathionemedicine.diseaseMalondialdehydeGlutathioneAcetylcysteineDisease Models AnimalchemistryCoronary occlusionAnesthesiaCardiologyFemalebusinessmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Hepatic extraction of isosorbide dinitrate in cardiac patients

1983

Hepatic extraction of organic nitrates, including that of isosorbide dinitrate (ISDN), has been thought to be nearly complete in man but has never been directly measured. We examined the time course of plasma ISDN and metabolite concentrations in arterial and hepatic venous blood in four cardiac patients receiving an intravenous ISDN infusion. Apparent hepatic extraction of ISDN was high (90%) at the beginning of infusion but fell to about 44% 1 hr after termination of infusion. The decrease in ISDN concentration gradient across the liver correlates with an increase in plasma isosorbide-5-mononitrate concentration, but a cause-and-effect relationship resulting from metabolite inhibition can…

Malemedicine.medical_specialtyMetaboliteBiological AvailabilityCoronary DiseaseIsosorbide DinitratePharmacologylaw.inventionchemistry.chemical_compoundlawInternal medicineHepatic extractionmedicineHumansInfusions ParenteralPharmacology (medical)In patientPharmacologyClinical pharmacologybusiness.industryVenous bloodMiddle AgedBioavailabilityKineticsEndocrinologyLiverchemistryTime courseIsosorbide dinitratebusinessmedicine.drugClinical Pharmacology and Therapeutics
researchProduct

Myasthenia-like syndrome induced by cardiovascular agents. Report of a case

1987

The case of a myasthenia-like syndrome induced by cardiovascular drugs is reported. The clinical and electrophysiological features of the case are discussed. © 1987 Masson Italia Periodici S.r.l.

Malemedicine.medical_specialtyNeurologyNeuromuscular JunctionCoronary DiseaseDermatologyPeruvosideMyasthenia-like syndromeSynaptic TransmissionPropafenoneimmune system diseasesMyasthenia GravisHumansMedicineperuvosideEtafenone hydrochlorideAgedNeuroradiologyOphthalmoplegiaNeuroscience (all)business.industryGeneral NeuroscienceGeneral Medicinenervous system diseasesCardenolidesPsychiatry and Mental healthAnesthesiaCardiovascular agentetafenone hydrochlorideDrug Therapy CombinationSettore MED/26 - NeurologiaNeurosurgeryNeurology (clinical)businessmedicine.drug
researchProduct

Noninvasive Visualization of an Apparent Patent Intracoronary Stent by Transesophageal Echocardiography

1995

In the area of increasing interventional techniques there is a need for noninvasive imaging modalities to provide postinterventional follow-up. We were able to visualize the apparent patency and measure the dimensions of an intracoronary Palmaz-Schatz stent in the left circumflex coronary artery using transesophageal two-dimensional echocardiography. This report indicates the potential of echocardiography to directly assess coronary stents.

Malemedicine.medical_specialtyNoninvasive imagingIntracoronary stentmedicine.medical_treatmentCoronary DiseaseCoronary AngiographyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesAngioplasty Balloon CoronaryVascular PatencyInterventional cardiologybusiness.industryStentMiddle Agedequipment and suppliesCoronary VesselsCardiologyLEFT CIRCUMFLEX CORONARY ARTERYStentsRadiologyCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealEchocardiography
researchProduct

Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients.

2008

OBJECTIVE: This is a multicentre, open label, prospective non-randomized registry, with 9-month angiographic follow-up, conducted to evaluate the safety and effectiveness of drug-eluting stents (DES) when used in high restenosis risk patients from the real world. METHODS: From June 2004 to February 2005, a total of 1622 consecutive patients were enrolled to the Sicilian DES Registry, according to specific inclusion criteria. Both paclitaxel-eluting and sirolimus-eluting stents were used. The analysis was performed on 1472 patients because 150 patients were excluded from the study. The primary endpoint was to evaluate the rate of major adverse cardiac events (MACE) within 9 months after DES …

Malemedicine.medical_specialtyPaclitaxelCoronary angioplastyRegistry.Target vessel revascularizationCoronary DiseaseCoronary AngiographyCoronary artery diseaseCoronary RestenosisRestenosisClinical endpointMedicineHumansCumulative incidencecardiovascular diseasesMyocardial infarctionDrug eluting stentRegistriesAngioplasty Balloon CoronarySicilyAgedSirolimusEjection fractionbusiness.industryIncidence (epidemiology)Drug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgeryFemaleCardiology and Cardiovascular MedicinebusinessMaceDiabetic AngiopathiesImmunosuppressive AgentsJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

2001

Background —Vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, and E-selectin mediate adhesion and transmigration of leukocytes to the vascular endothelial wall and may promote plaque growth and instability. In a prospective study, we evaluated the effect of soluble adhesion molecules on the risk of future cardiovascular events among patients with angiographically documented coronary artery disease (CAD). Methods and Results —We obtained baseline samples from a prospective cohort of 1246 patients with CAD. Besides various markers of inflammation, soluble VCAM-1 (sVCAM-1), sICAM-1, and sE-selectin were determined. Follow-up information on cardiovascular even…

Malemedicine.medical_specialtyPathologyIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1Coronary DiseaseInflammationSensitivity and SpecificityGastroenterologyCohort StudiesCoronary artery diseasePredictive Value of TestsRisk FactorsGermanyPhysiology (medical)Internal medicineE-selectinmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsbiologyCell adhesion moleculebusiness.industryMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseIntercellular adhesion moleculeThrombosisSurvival RateC-Reactive Proteinbiology.proteinFemalemedicine.symptomE-SelectinCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesFollow-Up StudiesCirculation
researchProduct

Physical activity as a preventive measure for coronary heart disease risk factors in early childhood.

2004

Physical activity causes acute physiological and long-term adaptive responses in the body. It is a protective factor for coronary heart disease (CHD) in adults. It has been assumed that children younger than 8 years of age may be in general active enough and there would be hardly any relationships between physical activity and CHD risk factors in early childhood. One hundred and fifty-five children (age 4-7 years) participated in this physical activity study during three consecutive years. Physical activity was examined twice a year with a special-purpose physical activity diary. CHD risk factors were measured during annual health care visits in the Specific Turku Coronary Risk-Factor Inter…

Malemedicine.medical_specialtyPediatricsProtective factorPhysical activityPhysical Therapy Sports Therapy and RehabilitationBlood PressureCoronary DiseaseGrowthRisk FactorsInternal medicinemedicineHumansOrthopedics and Sports MedicineEarly childhoodChildExerciseFinlandbusiness.industrySerum HDL cholesterolLipidsCoronary heart diseaseBlood pressureChild PreschoolFemalebusinessChd riskLipoproteinScandinavian journal of medicinescience in sports
researchProduct

Analysis of risk factors for restenosis after PTCA

1990

To identify risk factors for restenosis, we evaluated data in 473 patients with single-vessel percutaneous transluminal coronary angioplasty (PTCA) and control angiography after 6 months. Restenosis, defined as (1) loss greater than 50% of the initial gain, and (2) stenosis greater than 50% was found in 138 patients (29.2%). Univariate analysis revealed eight factors related to restenosis: (1) duration of symptoms less than 1 month (P = 0.005), (2) unstable angina (P = 0.004), (3) high-grade stenosis before PTCA (P = 0.014), (4) large residual stenosis after PTCA (P = 0.001), (5) insufficient improvement of stenosis (P = 0.042), (6) prolonged single inflation time (P = 0.017), (7) prolonged…

Malemedicine.medical_specialtyPercutaneous transluminal coronary angioplastyCoronary DiseaseCoronary AngiographyRestenosisRecurrenceRisk FactorsInternal medicinemedicineHumansAngina Unstablecardiovascular diseasesAngioplasty Balloon CoronaryAgedAnalysis of VarianceUnivariate analysismedicine.diagnostic_testbusiness.industryUnstable anginaResidual stenosisMiddle Agedmedicine.diseaseCoronary VesselsStenosisAngiographyCardiologyEvaluated dataCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Diagnosis
researchProduct